These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34528072)

  • 1. Expression of parathormone receptor on B-lymphocytes in systemic lupus erythematosus and Sjögren's syndrome.
    Rios-Serna LJ; Nieto-Aristizábal I; Ruiz-Ordoñez I; Mendez-Rayo T; Posso-Osorio I; García J; Navarro EP; Barrera MC; Aguirre-Valencia D; Cañas CA; Tobón GJ
    Rheumatology (Oxford); 2021 Dec; 60(12):5869-5872. PubMed ID: 34528072
    [No Abstract]   [Full Text] [Related]  

  • 2. Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren's syndrome.
    van der Goes MC; Bossema ER; Hartkamp A; Godaert GL; Jacobs JW; Kruize AA; Derksen RH; Bijlsma JW; Geenen R
    J Rheumatol; 2011 Feb; 38(2):285-8. PubMed ID: 21159832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome.
    Chen JQ; Papp G; Póliska S; Szabó K; Tarr T; Bálint BL; Szodoray P; Zeher M
    PLoS One; 2017; 12(3):e0174585. PubMed ID: 28339495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency of CCR7
    Wu C; Yang P; Liu H; Xiao W; Zhao L
    Cytokine; 2018 Oct; 110():9-17. PubMed ID: 29684636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of chronic lymphocytic leukaemia in a case of Sjögren's syndrome with systemic lupus erythematosus.
    Ho CH; Chiang YM; Chong LL; Lin HY; Hwang TS
    Scand J Haematol; 1985 Aug; 35(2):246-8. PubMed ID: 3876599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis.
    Masilamani M; Nowack R; Witte T; Schlesier M; Warnatz K; Glocker MO; Peter HH; Illges H
    Scand J Immunol; 2004 Dec; 60(6):625-30. PubMed ID: 15584974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xerostomia in Sjögren's syndrome and lupus erythematosus: a comparative histological and immunofluorescence study of minor salivary glands alterations.
    Fernandes JD; Nico MM; Aoki V; Bologna S; Romiti R; Levy-Neto M; Lourenço SV
    J Cutan Pathol; 2010 Apr; 37(4):432-8. PubMed ID: 19614726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis.
    Bengtsson AA; Trygg J; Wuttge DM; Sturfelt G; Theander E; Donten M; Moritz T; Sennbro CJ; Torell F; Lood C; Surowiec I; Rännar S; Lundstedt T
    PLoS One; 2016; 11(7):e0159384. PubMed ID: 27441838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of exercise in the rehabilitation of patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.
    Strömbeck B; Jacobsson LT
    Curr Opin Rheumatol; 2007 Mar; 19(2):197-203. PubMed ID: 17278938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison in T- and B-cell markers in patients with Sjögren's syndrome and systemic lupus erythematosus.
    Morimoto C; Reinherz EL; Nadler LM; Distaso JA; Steinberg AD; Schlossman SF
    Clin Immunol Immunopathol; 1982 Feb; 22(2):270-8. PubMed ID: 6213332
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
    Blokland SLM; Hillen MR; Wichers CGK; Zimmermann M; Kruize AA; Radstake TRDJ; Broen JCA; van Roon JAG
    RMD Open; 2019; 5(1):e000701. PubMed ID: 30713717
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome.
    Alexander EL; McNicholl J; Watson RM; Bias W; Reichlin M; Provost TT
    J Invest Dermatol; 1989 Dec; 93(6):751-6. PubMed ID: 2584740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
    Hamm-Alvarez SF; Janga SR; Edman MC; Madrigal S; Shah M; Frousiakis SE; Renduchintala K; Zhu J; Bricel S; Silka K; Bach D; Heur M; Christianakis S; Arkfeld DG; Irvine J; Mack WJ; Stohl W
    Arthritis Rheumatol; 2014 Jul; 66(7):1872-81. PubMed ID: 24644101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjögren's syndrome in lupus-prone female NZB × NZWF(1) mice.
    Hayashi T; Shimoyama N; Mizuno T
    Inflammation; 2012 Apr; 35(2):638-46. PubMed ID: 21786007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell depletion in lupus and Sjögren's syndrome: an update.
    Coca A; Sanz I
    Curr Opin Rheumatol; 2009 Sep; 21(5):483-8. PubMed ID: 19644378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oral component of Sjögren's syndrome.
    Daniels TE; Silverman S; Michalski JP; Greenspan JS; Sylvester RA; Talal N
    Oral Surg Oral Med Oral Pathol; 1975 Jun; 39(6):875-85. PubMed ID: 1055974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
    Fox RI; Kang HI; Ando D; Abrams J; Pisa E
    J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome.
    Awada A; Nicaise C; Ena S; Schandéné L; Rasschaert J; Popescu I; Gangji V; Soyfoo MS
    Ann Rheum Dis; 2014 Jun; 73(6):1259-63. PubMed ID: 24385203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.